Yasmin: Reliable Hormonal Contraception with Acne Control
| Product dosage: 3.03mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 42 | $1.51 | $63.37 $63.37 (0%) | 🛒 Add to cart |
| 63 | $1.44 | $95.06 $90.54 (5%) | 🛒 Add to cart |
| 84 | $1.39 | $126.75 $116.69 (8%) | 🛒 Add to cart |
| 126 | $1.36 | $190.12 $171.01 (10%) | 🛒 Add to cart |
| 168 | $1.34
Best per pill | $253.50 $224.33 (12%) | 🛒 Add to cart |
Synonyms | |||
Yasmin is a combined oral contraceptive pill designed to provide effective pregnancy prevention while offering additional dermatological benefits. It contains a balanced formulation of ethinylestradiol and drospirenone, which work synergistically to inhibit ovulation and regulate hormonal fluctuations. Trusted by healthcare professionals worldwide, Yasmin represents a sophisticated option for women seeking both contraceptive efficacy and improved skin health.
Features
- Contains 0.03 mg ethinylestradiol and 3 mg drospirenone per active tablet
- 21 active tablets and 7 placebo tablets per blister pack
- Monophasic hormone delivery for consistent dosing
- Anti-mineralocorticoid activity of drospirenone
- Anti-androgenic properties for dermatological benefits
- Manufactured under strict pharmaceutical quality standards
Benefits
- Provides highly effective contraception when taken correctly
- Reduces moderate acne vulgaris in women seeking contraception
- Helps regulate menstrual cycles and reduce menstrual pain
- May decrease water retention and bloating associated with hormonal fluctuations
- Offers potential improvement in premenstrual symptoms
- Provides predictable withdrawal bleeding patterns
Common use
Yasmin is primarily prescribed for contraception in women of reproductive age. Additionally, it is indicated for the treatment of moderate acne vulgaris in women at least 14 years old who have no known contraindications to oral contraceptives, have achieved menarche, and desire contraception. The acne-improving effects typically become noticeable after several months of continuous use.
Dosage and direction
Take one tablet daily at approximately the same time each day for 28 consecutive days: 21 active tablets followed by 7 placebo tablets. Begin each new pack the day after finishing the previous pack, regardless of whether menstrual bleeding has occurred. For first-time users, start taking Yasmin on the first day of menstrual bleeding or as directed by a healthcare provider. Swallow tablets whole with water; taking with food may reduce nausea.
Precautions
Regular medical supervision is required during treatment. Blood pressure should be monitored periodically. Women should be advised that oral contraceptives do not protect against HIV infection or other sexually transmitted diseases. Smoking increases the risk of serious cardiovascular side effects, especially in women over 35 years old. The risk of venous thromboembolism is highest during the first year of use and when restarting after a break of four or more weeks.
Contraindications
- Thrombophlebitis or thromboembolic disorders
- History of deep vein thrombosis or pulmonary embolism
- Cerebrovascular or coronary artery disease
- Known or suspected carcinoma of the breast or estrogen-dependent neoplasia
- Undiagnosed abnormal genital bleeding
- Cholestatic jaundice of pregnancy or jaundice with prior pill use
- Hepatic adenomas or carcinomas
- Known or suspected pregnancy
- Severe hypertension
- Diabetes with vascular involvement
- Headaches with focal neurological symptoms
- Major surgery with prolonged immobilization
Possible side effects
Common side effects may include nausea, headache, breast tenderness, irregular bleeding, and mood changes. Less frequently reported effects include weight changes, decreased libido, and contact lens intolerance. Serious but rare side effects include venous thromboembolism, arterial thromboembolism, hypertension, hepatic tumors, gallbladder disease, and carbohydrate metabolism effects. Any unusual symptoms should be reported immediately to a healthcare provider.
Drug interaction
Yasmin’s effectiveness may be reduced by drugs that induce hepatic enzymes, including rifampicin, barbiturates, carbamazepine, phenytoin, primidone, topiramate, and certain HIV medications. Antibiotics such as ampicillin and tetracycline may decrease estrogen concentrations. Drospirenone may increase potassium levels, particularly when used with other potassium-sparing drugs or in women with renal insufficiency. Consult a healthcare provider about all medications being taken, including over-the-counter products and herbal supplements.
Missed dose
If one active tablet is missed (less than 24 hours late), take it as soon as remembered and continue the schedule normally. If missed by more than 24 hours, follow specific guidance based on the week of the cycle: during week 1, use backup contraception for 7 days; during week 2, continue normally if no tablets were missed in previous week; during week 3, either discard the current pack and start a new pack immediately or finish active tablets and omit placebo tablets. Consult package insert or healthcare provider for detailed instructions.
Overdose
Serious ill effects have not been reported following overdose of oral contraceptives. Overdose may cause nausea, vomiting, and withdrawal bleeding in females. There is no specific antidote; treatment should be symptomatic and supportive. Medical attention should be sought if large amounts are ingested, particularly by children.
Storage
Store at room temperature (15-30°C) in the original blister pack to protect from light and moisture. Keep out of reach of children. Do not use after the expiration date printed on the packaging. Properly dispose of any unused medication according to local regulations.
Disclaimer
This information is for educational purposes only and does not replace professional medical advice. Yasmin is available by prescription only and should be used under medical supervision. Individual results may vary, and not all users will experience the same benefits or side effects. The prescribing physician should be consulted regarding specific health concerns and appropriate contraceptive choices.
Reviews
Clinical studies demonstrate Yasmin’s high efficacy in pregnancy prevention, with a Pearl Index of approximately 0.40-1.27. Users report satisfaction with both contraceptive reliability and dermatological improvements, though individual experiences with side effects vary. Healthcare professionals appreciate its balanced hormonal profile and additional non-contraceptive benefits. Long-term safety data continue to support its appropriate use in suitable candidates under medical guidance.